Palvella Therapeutics Announces Issuance of European Patent Covering Anhydrous Compositions of Rapamycin

Go back to Palvella Therapeutics Announces Issuance of European Patent Covering Anhydrous Compositions of Rapamycin
(NASDAQ: PVLA) Delayed: 146.76 +8.50 (6.15%)
Previous Close $138.26    52 Week High
Open $138.58    52 Week Low
Day High $146.88    P/E N/A 
Day Low $136.77    EPS
Volume 321,856